Higaki M - Search Results

1

Pharmacokinetics and enhanced PKR response in patients with chronic hepatitis C treated with pegylated interferon alpha-2b and ribavirin.

Asahina Y, Izumi N, Umeda N, Hosokawa T, Ueda K, Doi F, Tsuchiya K, Nakanishi H, Matsunaga K, Kitamura T, Kurosaki M, Uchihara M, Higaki M, Miyake S. Asahina Y, et al. Among authors: higaki m. J Viral Hepat. 2007 Jun;14(6):396-403. doi: 10.1111/j.1365-2893.2006.00803.x. J Viral Hepat. 2007. PMID: 17501760 Clinical Trial.

2

A predictive model of response to peginterferon ribavirin in chronic hepatitis C using classification and regression tree analysis.

Kurosaki M, Matsunaga K, Hirayama I, Tanaka T, Sato M, Yasui Y, Tamaki N, Hosokawa T, Ueda K, Tsuchiya K, Nakanishi H, Ikeda H, Itakura J, Takahashi Y, Asahina Y, Higaki M, Enomoto N, Izumi N. Kurosaki M, et al. Among authors: higaki m. Hepatol Res. 2010 Apr;40(4):251-60. doi: 10.1111/j.1872-034X.2009.00607.x. Epub 2010 Jan 11. Hepatol Res. 2010. PMID: 20070391

3

Transdermal delivery of CaCO3-nanoparticles containing insulin.

Higaki M, Kameyama M, Udagawa M, Ueno Y, Yamaguchi Y, Igarashi R, Ishihara T, Mizushima Y. Higaki M, et al. Diabetes Technol Ther. 2006 Jun;8(3):369-74. doi: 10.1089/dia.2006.8.369. Diabetes Technol Ther. 2006. PMID: 16800758

4

Treatment of experimental arthritis with stealth-type polymeric nanoparticles encapsulating betamethasone phosphate.

Ishihara T, Kubota T, Choi T, Higaki M. Ishihara T, et al. Among authors: higaki m. J Pharmacol Exp Ther. 2009 May;329(2):412-7. doi: 10.1124/jpet.108.150276. Epub 2009 Feb 25. J Pharmacol Exp Ther. 2009. PMID: 19244548

5

Collagen minipellet as a controlled release delivery system for tetanus and diphtheria toxoid.

Higaki M, Azechi Y, Takase T, Igarashi R, Nagahara S, Sano A, Fujioka K, Nakagawa N, Aizawa C, Mizushima Y. Higaki M, et al. Vaccine. 2001 Apr 30;19(23-24):3091-6. doi: 10.1016/s0264-410x(01)00039-1. Vaccine. 2001. PMID: 11312003

6

Effect of a soluble pseudo-receptor on verotoxin 2-induced toxicity.

Takenaga M, Igarashi R, Higaki M, Nakayama T, Yuki K, Mizushima Y. Takenaga M, et al. Among authors: higaki m. J Infect Chemother. 2000 Mar;6(1):21-5. doi: 10.1007/s101560050044. J Infect Chemother. 2000. PMID: 11810526

7

Enhancement of immune response to intranasal influenza HA vaccine by microparticle resin.

Higaki M, Takase T, Igarashi R, Suzuki Y, Aizawa C, Mizushima Y. Higaki M, et al. Vaccine. 1998 Apr;16(7):741-5. doi: 10.1016/s0264-410x(97)00248-x. Vaccine. 1998. PMID: 9562695

8

Suppressive effects of the new antirheumatic drug KE-298 on TNF alpha-induced production of matrix metalloproteinases but not of tissue inhibitor-1 of metalloproteinases in human rheumatoid synoviocytes.

Takahashi S, Inoue T, Higaki M, Mizushima Y. Takahashi S, et al. Among authors: higaki m. Drugs Exp Clin Res. 1998;24(2):67-71. Drugs Exp Clin Res. 1998. PMID: 9675546

9

Polymeric nanoparticles encapsulating betamethasone phosphate with different release profiles and stealthiness.

Ishihara T, Kubota T, Choi T, Takahashi M, Ayano E, Kanazawa H, Higaki M. Ishihara T, et al. Among authors: higaki m. Int J Pharm. 2009 Jun 22;375(1-2):148-54. doi: 10.1016/j.ijpharm.2009.04.001. Epub 2009 Apr 10. Int J Pharm. 2009. PMID: 19481700

10

Therapeutic effect of stealth-type polymeric nanoparticles with encapsulated betamethasone phosphate on experimental autoimmune uveoretinitis.

Sakai T, Ishihara T, Higaki M, Akiyama G, Tsuneoka H. Sakai T, et al. Among authors: higaki m. Invest Ophthalmol Vis Sci. 2011 Mar 18;52(3):1516-21. doi: 10.1167/iovs.10-5676. Invest Ophthalmol Vis Sci. 2011. PMID: 21178146

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

152 results

Search Page